Journals / Medicine Science / 2021 / Cilt: 10 - Sayı: 2

Clinical significance of preoperative neutrophil to lymphocyte ratio in organ-confined urothelial bladder cancer

Pages
310–316
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, based on the other positive correlations we have obtained, we think that NLR evaluated before transurethral resection may be a valuable parameter in predicting the operative pathology result.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:We aimed to investigate the relationship between the preoperative neutrophil to lymphocyte ratio (NLR) and the postoperative tumor stage and grade in patients with organ- confined urothelial bladder cancer.
📊
Key Findings & Data:We examined 308 patients who underwent transurethral resection in our clinic.
💡
Conclusion & Impact:However, based on the other positive correlations we have obtained, we think that NLR evaluated before transurethral resection may be a valuable parameter in predicting the operative pathology result.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

We aimed to investigate the relationship between the preoperative neutrophil to lymphocyte ratio (NLR) and the postoperative tumor stage and grade in patients with organ- confined urothelial bladder cancer. We examined 308 patients who underwent transurethral resection in our clinic. Our study only included patients whose pathology results were organ-confined urothelial bladder cancer. The patients were classified according to tumor stage (Ta, T1, and T2) and tumor grade (Grade 1 and 2, indicating a low-grade; Grade 3, referring to a high-grade). Then each group was compared within itself based on the NLR evaluated before the surgery. A total of 279 cases (90.6%) were male. The mean age, tumor size, neutrophil and lymphocyte counts of the patients were 69.33±10.92 years, 2.99±2.35 cm, 5.36±1.99 K/uL, and 2.23±0.78 K/uL, respectively. Inflammation parameters regarding the cancer stage were as follows: NLR was 2.08, 2.36, and 3.07, for Ta, T1, and T2 tumors respectively. The relationship between T1 and T2 tumors and Ta and T2 tumors was significant (p <0.001, p <0.001). But there was no significant difference between the Ta and T1 tumors (p: 0.142). NLR was 2.07 and 2.78 for low- and high-grade tumors, respectively. These values were statistically significant (p <0.001). We could not statistically correlate between Ta and T1 tumors. However, based on the other positive correlations we have obtained, we think that NLR evaluated before transurethral resection may be a valuable parameter in predicting the operative pathology result.

🔖

Cite This Article

KOLUKCU, E., UNSAL, V., ÖZBEK, L. M., DEMİR, O. (2021). Clinical significance of preoperative neutrophil to lymphocyte ratio in organ-confined urothelial bladder cancer. Medicine Science, Cilt: 10 - Sayı: 2, 310–316. https://ajindex.com/articles/397517

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Ploeg M, Aben KK, Kiemeney LA. The present and future burden of urinary bladder cancer in the world. World J Urol.2009;289. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70:7-30. Yaxley JP. Urinary tract cancers: An overview for general practice. Family Med Prim Care.2016;5:533-8.
  2. Değer D, Aslan ÖD, Çömez K, et al. Social Awareness on Early Diagnosis and Treatment of Bladder Cancer: Importance of age and education. Bull Urooncol.2017;16:12-6.
  3. Vartolomei MD, Porav-Hodade D, Ferro M, et al. Prognostic role of pretreatment neutrophil-to-lymphocyte ratio (NLR) in patients with nonmuscle- invasive bladder cancer (NMIBC): A systematic review and metaanalysis. Urol Oncol. 2018;389-99
  4. Cendan JC, Behrns KE. Associated neoplastic disease in inflammatory bowel disease. Surg Clin North Am. 2007;87:659-72.
  5. Tang X, Du P, Yang Y. The clinical use of neutrophil-to-lymphocyte ratio in bladder cancer patients: a systematic review and meta-analysis. Int J Clin Oncol. 2017;22:817-25.
  6. Cheng L, Montironi R, Davidson DD, et al. Staging and reporting of urothelial carcinoma of the urinary bladder. Mod Pathol. 2009;22:70-95. Erdem SS. Over and Under 65 Years of Age Distribution of Cancer Diagnosisin a University Hospital in 2013. Duzce Med J. 2015;17:105-10.
  7. Wei Y, Jiang YZ, Qian WH. Prognostic role of NLR in urinary system cancers: a meta-analysis. PLoS One. 2014;9:e92079.
  8. Su S, Liu L, Li C, et al. Prognostic role of pretreatment derived neutrophil to lymphocyte ratio in urological cancers: A systematic review and metaanalysis. Int J Surg. 2019;72:146-53.
  9. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140:883-99.
  10. Richards CH, Mohammed Z, Qayyum T, et al. The prognostic value of histological tumour necrosis in solid organ malignant disease: a systematic review. Future Oncol. 2011;7:1223-35.
  11. Richard CH, Roxburgh CSD, Anderson JH, et al. Prognostic value of tumour necrosis and host inflammatory responses in colorectal cancer. Br J Surg. 2012;99:287-94.
  12. Germano G, Allavena P, Mantovani A. Cytokines as a key component ofcancer-related inflammation. Cytokine. 2008;43:374-79.
  13. Taniguchi K, Karin M. IL-6 and related cytokines as the critical lynchpins between infl ammation and cancer. Semin Immunol. 2014;26:54-74.
  14. Luo Y, She DL, Xiong H, et al. Pretreatment neutrophil to lymphocyte ratio as a prognostic predictor of urologic tumors: A systematic review and metaanalysis. Medicine (Baltimore). 2015;94:1670. Dai J, Tang K,